Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Access to HIV Pre-exposure Prophylaxis: Implementation and Evaluation of Innovative HIV Prevention Services Among Persons on Opioid Replacement Therapy in Western Canada: Prospective, Implementation Study

NCT07160075 is registered in ClinicalTrials.gov with Cara Spence as lead sponsor.

NCT NCT07160075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07160075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Access to HIV Pre-exposure Prophylaxis: Implementation and Evaluation of Innovative HIV Prevention Services Among Persons on Opioid Replacement Therapy in Western Canada: Prospective, Implementation Study
Lead sponsor
Cara Spence
Phase
Phase 4
Overall status
Recruiting
Start date
August 28, 2025
Completion date
September 1, 2027
Enrollment
350 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hiv - human immunodeficiency virus